METHYLPHENIDATE ALLEVIATES FATIGUE IN HAEMATOLOGICAL CANCER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER TRIAL - THE MICRO TRIAL
EHA Library, Henrik Frederiksen,
4159404
ASSESSMENT OF THE IMPACT OF DEMOGRAPHICS, INFORMATION PROVISION, AND INVOLVEMENT IN TREATMENT DECISION ON LEUKAEMIA PATIENTS' QUALITY OF LIFE: PRIMARY ANALYSIS OF GLOBAL STUDY DATA
EHA Library, Samantha Nier,
4159405
ISATUXIMAB SUBCUTANEOUS VIA AN ON-BODY DELIVERY SYSTEM VERSUS ISATUXIMAB INTRAVENOUS, PLUS POMALIDOMIDE AND DEXAMETHASONE, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE RANDOMIZED PHASE 3 IRAKLIA STUDY
EHA Library, Xavier Leleu,
4159280
POLATUZUMAB VEDOTIN, RITUXIMAB, GEMCITABINE AND OXALIPLATIN (POLA-R-GEMOX) FOR RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): RESULTS FROM THE RANDOMIZED PHASE III POLARGO TRIAL
EHA Library, Matthew Matasar,
4159178
FIRST-IN-HUMAN STUDY OF JNJ-79635322 (JNJ-5322), A NOVEL, NEXT-GENERATION TRISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL PHASE 1 RESULTS
EHA Library, Rakesh Popat,
4159177